Beyond animal models: using human pluripotent stem cell-derived stem and progenitor cells to predict cytotoxicity in normal tissues
Pathology & Oncology Research · 20.08.2026 · 32
DOI: 10.3389/pore.2026.1612490 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology & Oncology Research, online erschienen am 20.08.2026. Verfasst von Katalin Vincze und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Life Sciences, HUN-REN Research Center for Natural Sciences, Budapest, Hungary. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Antineoplastic Agents, Pluripotent Stem Cells, Mesenchymal Stem Cells. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The clinical efficacy of anticancer drugs is often limited by dose-dependent toxicity to normal cells, particularly to rapidly dividing stem and progenitor cell populations. Traditional preclinical toxicity screening relies on animal models or primary human cells/immortalized lines, both of which have significant limitations regarding scalability, reproducibility, genetic diversity, and translational relevance.
Objective
This study aims to establish and validate a human pluripotent stem cell -based platform for profiling the toxicity of cytostatic drugs on healthy, dividing cell populations, and to compare their sensitivity to that of cancer cell lines.
Methods
Two hiPSC lines (male and female) were reprogrammed from umbilical cord blood cells, fully characterized, and differentiated into neural progenitors and mesenchymal derivatives. Dose–response curves were generated using a dilution series of four anticancer drugs and four other pharmacologically active compounds based on cell viability. Toxic half-maximal values (IC 50 ) were determined for each cell type and compared to those obtained from conventional cancer cell lines.
Results
The highest sensitivity to DNA-damaging agents was exhibited by pluripotent stem cells, followed by neural progenitors, with mesenchymal derivatives being the least sensitive. Notably, except for mesenchymal cells, both pluripotent stem cells and their differentiated derivatives were more sensitive to cytostatics than cancer cell lines.
Conclusion
Human iPSC-derived stem/progenitor cells recapitulate the in vivo sensitivity of healthy dividing cell populations to chemotherapy. This platform offers unlimited, genetically consistent, and reproducible access to human cells, rendering it as a powerful complementary approach or even an alternative to animal models and primary human cells for early-phase drug safety profiling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Molecular Life Sciences, HUN-REN Research Center for Natural Sciences, Budapest, Hungary.
- Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary.
- Salus Ltd., Budapest, Hungary.
- Regenerative Medicine and Cellular Pharmacology Laboratory, Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary.
- Innocell Ltd., Budapest, Hungary.
Zitieren
APA
Vincze, K., Varga, N., Tóth, S., Kis, A. K., Béres, R., Réthelyi, J. M., Veréb, Z. J., Erdei, Z., Sarkadi, B., & Apáti, Á. (2026). Beyond animal models: using human pluripotent stem cell-derived stem and progenitor cells to predict cytotoxicity in normal tissues. Pathology & Oncology Research, 32. https://doi.org/10.3389/pore.2026.1612490
Vancouver
Vincze K, Varga N, Tóth S, Kis AK, Béres R, Réthelyi JM, et al. Beyond animal models: using human pluripotent stem cell-derived stem and progenitor cells to predict cytotoxicity in normal tissues. Pathology & Oncology Research. 2026;32. doi:10.3389/pore.2026.1612490
BibTeX
@article{Vincze2026,
author = {Vincze, Katalin and Varga, Nóra and Tóth, Szilárd and Kis, Anna Kamilla and Béres, Rita and Réthelyi, János Miklós and Veréb, Zoltán János and Erdei, Zsuzsa and Sarkadi, Balázs and Apáti, Ágota},
title = {Beyond animal models: using human pluripotent stem cell-derived stem and progenitor cells to predict cytotoxicity in normal tissues},
journal = {Pathology & Oncology Research},
year = {2026},
volume = {32},
doi = {10.3389/pore.2026.1612490}
}
EUVIMED